NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression

Journal of Immunology

Volumn 188, Issue 10, 2012, Pages 4951-4958

  Meissner, Torsten B ^a,b   Liu, Yuen Joyce ^a   Lee, Kyoung Hee ^a,b   Li, Amy ^a   Biswas, Amlan ^a,b   Van Eggermond, Marja C J A ^c   Van Den Elsen, Peter J ^c,d   Kobayashi, Koichi S ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENHANCEOSOME; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT PROTEIN; NUCLEOTIDE BINDING PROTEIN; PROTEIN NLRC5; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RFX; TRANSCRIPTION FACTOR RFX5; TRANSCRIPTION FACTOR RFXANK; TRANSCRIPTION FACTOR RFXAP; UNCLASSIFIED DRUG;

ARTICLE; CIS REGULATORY ELEMENT; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENE STRUCTURE; HUMAN; HUMAN CELL; MHC CLASS I GENE; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION INITIATION;

ACTIVATING TRANSCRIPTION FACTOR 1; AMINO ACID MOTIFS; CELL LINE; CELL LINE, TUMOR; DNA-BINDING PROTEINS; HEK293 CELLS; HLA-B ANTIGENS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIGENE FAMILY; PROMOTER REGIONS, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84861116563     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103160     Document Type: Article

References (52)

1. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11: 403-450. (Pubitemid 23115014)
2. Oldstone, M. B. 1996. Virus-lymphoid cell interactions. Proc. Natl. Acad. Sci. USA 93: 12756-12758. (Pubitemid 26382714)
3. Pamer, E., and P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16: 323-358. (Pubitemid 28183368)
4. Braud, V. M., D. S. Allan, and A. J. McMichael. 1999. Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr. Opin. Immunol. 11: 100-108. (Pubitemid 29082345)
5. Le Bouteiller, P., and C. Solier. 2001. Is antigen presentation the primary function of HLA-G? Microbes Infect. 3: 323-332. (Pubitemid 32385782)
6. Shastri, N., S. Cardinaud, S. R. Schwab, T. Serwold, and J. Kunisawa. 2005. All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway. Immunol. Rev. 207: 31-41. (Pubitemid 41415006)
7. Peaper, D. R., and P. Cresswell. 2008. Regulation of MHC class I assembly and peptide binding. Annu. Rev. Cell Dev. Biol. 24: 343-368.
8. Reith, W., and B. Mach. 2001. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 19: 331-373. (Pubitemid 32368039)
9. van den Elsen, P. J., S. J. Gobin, M. C. van Eggermond, and A. Peijnenburg. 1998. Regulation of MHC class I and II gene transcription: differences and similarities. Immunogenetics 48: 208-221. (Pubitemid 28352187)
10. van den Elsen, P. J., A. Peijnenburg, M. C. van Eggermond, and S. J. Gobin. 1998. Shared regulatory elements in the promoters of MHC class I and class II genes. Immunol. Today 19: 308-312. (Pubitemid 28322326)
11. Gobin, S. J., M. van Zutphen, S. D. Westerheide, J. M. Boss, and P. J. van den Elsen. 2001. The MHC-specific enhanceosome and its role in MHC class I and beta(2)-microglobulin gene transactivation. J. Immunol. 167: 5175-5184. (Pubitemid 33009754)
12. Ting, J. P., and J. Trowsdale. 2002. Genetic control of MHC class II expression. Cell 109(Suppl.): S21-S33. (Pubitemid 34457849)
13. Steimle, V., B. Durand, E. Barras, M. Zufferey, M. R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9: 1021-1032.
14. Durand, B., P. Sperisen, P. Emery, E. Barras, M. Zufferey, B. Mach, and W. Reith. 1997. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16: 1045-1055. (Pubitemid 27113183)
15. Masternak, K., E. Barras, M. Zufferey, B. Conrad, G. Corthals, R. Aebersold, J. C. Sanchez, D. F. Hochstrasser, B. Mach, and W. Reith. 1998. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20: 273-277. (Pubitemid 28507672)
16. Nagarajan, U. M., P. Louis-Plence, A. DeSandro, R. Nilsen, A. Bushey, and J. M. Boss. 1999. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity 10: 153-162. (Pubitemid 29115621)
17. Moreno, C. S., G. W. Beresford, P. Louis-Plence, A. C. Morris, and J. M. Boss. 1999. CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity 10: 143-151. (Pubitemid 29115620)
18. Louis-Plence, P., C. S. Moreno, and J. M. Boss. 1997. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. J. Immunol. 159: 3899-3909. (Pubitemid 127469646)
19. Jabrane-Ferrat, N., N. Nekrep, G. Tosi, L. J. Esserman, and B. M. Peterlin. 2002. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers. Mol. Cell. Biol. 22: 5616-5625. (Pubitemid 34755770)
20. Boss, J. M., and P. E. Jensen. 2003. Transcriptional regulation of the MHC class II antigen presentation pathway. Curr. Opin. Immunol. 15: 105-111. (Pubitemid 35454200)
21. Masternak, K., A. Muhlethaler-Mottet, J. Villard, M. Zufferey, V. Steimle, and W. Reith. 2000. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 14: 1156-1166. (Pubitemid 30324428)
22. Wilmanski, J. M., T. Petnicki-Ocwieja, and K. S. Kobayashi. 2008. NLR proteins: integral members of innate immunity and mediators of inflammatory diseases. J. Leukoc. Biol. 83: 13-30.
23. Ting, J. P., R. C. Lovering, E. S. Alnemri, J. Bertin, J. M. Boss, B. K. Davis, R. A. Flavell, S. E. Girardin, A. Godzik, J. A. Harton, et al. 2008. The NLR gene family: a standard nomenclature. Immunity 28: 285-287. (Pubitemid 351350631)
24. Beresford, G. W., and J. M. Boss. 2001. CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter. Nat. Immunol. 2: 652-657. (Pubitemid 32677634)
25. DeSandro, A., U. M. Nagarajan, and J. M. Boss. 1999. The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes. Am. J. Hum. Genet. 65: 279-286. (Pubitemid 30462984)
26. Steimle, V., C. A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265: 106-109. (Pubitemid 24253184)
27. LeibundGut-Landmann, S., J. M. Waldburger, M. Krawczyk, L. A. Otten, T. Suter, A. Fontana, H. Acha-Orbea, and W. Reith. 2004. Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol. 34: 1513-1525.
28. Wong, A. W., N. Ghosh, K. P. McKinnon, W. Reed, J. F. Piskurich, K. L. Wright, and J. P. Ting. 2002. Regulation and specificity of MHC2TA promoter usage in human primary T lymphocytes and cell line. J. Immunol. 169: 3112-3119. (Pubitemid 35013156)
29. Holling, T. M., N. van der Stoep, E. Quinten, and P. J. van den Elsen. 2002. Activated human T cells accomplish MHC class II expression through T cellspecific occupation of class II transactivator promoter III. J. Immunol. 168: 763-770. (Pubitemid 34049577)
30. Martin, B. K., K. C. Chin, J. C. Olsen, C. A. Skinner, A. Dey, K. Ozato, and J. P. Ting. 1997. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6: 591-600. (Pubitemid 27239350)
31. Gobin, S. J., A. Peijnenburg, V. Keijsers, and P. J. van den Elsen. 1997. Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 6: 601-611. (Pubitemid 27239351)
32. Bénichou, B., and J. L. Strominger. 1991. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. USA 88: 4285-4288. (Pubitemid 21914524)
33. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75: 135-146. (Pubitemid 23306027)
34. Chang, C. H., S. Guerder, S. C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4: 167-178. (Pubitemid 26093162)
35. Itoh-Lindstrom, Y., J. F. Piskurich, N. J. Felix, Y. Wang, W. J. Brickey, J. L. Platt, B. H. Koller, and J. P. Ting. 1999. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma- induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. J. Immunol. 163: 2425-2431. (Pubitemid 29399161)
36. Williams, G. S., M. Malin, D. Vremec, C. H. Chang, R. Boyd, C. Benoist, and D. Mathis. 1998. Mice lacking the transcription factor CIITA-a second look. Int. Immunol. 10: 1957-1967. (Pubitemid 28566058)
37. Meissner, T. B., A. Li, A. Biswas, K. H. Lee, Y. J. Liu, E. Bayir, D. Iliopoulos, P. J. van den Elsen, and K. S. Kobayashi. 2010. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc. Natl. Acad. Sci. USA 107: 13794-13799.
38. Meissner, T. B., A. Li, Y. J. Liu, E. Gagnon, and K. S. Kobayashi. 2012. The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity. Biochem. Biophys. Res. Commun. 418: 786-791.
39. Meissner, T. B., A. Li, and K. S. Kobayashi. 2012. NLRC5: a newly discovered MHC class I transactivator (CITA). Microbes Infect. In press.
40. Gobin, S. J., A. Peijnenburg, M. van Eggermond, M. van Zutphen, R. van den Berg, and P. J. van den Elsen. 1998. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2- microglobulin genes. Immunity 9: 531-541. (Pubitemid 28499204)
41. Gobin, S. J., M. van Zutphen, A. M. Woltman, and P. J. van den Elsen. 1999. Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J. Immunol. 163: 1428-1434. (Pubitemid 29352763)
42. Villard, J., B. Lisowska-Grospierre, P. van den Elsen, A. Fischer, W. Reith, and B. Mach. 1997. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. N. Engl. J. Med. 337: 748-753. (Pubitemid 27417974)
43. Peijnenburg, A., M. C. Van Eggermond, R. Van den Berg, O. Sanal, J. M. Vossen, and P. J. Van den Elsen. 1999. Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene. Immunogenetics 49: 338-345. (Pubitemid 29119044)
44. Nagarajan, U. M., A. Peijnenburg, S. J. Gobin, J. M. Boss, and P. J. van den Elsen. 2000. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells. J. Immunol. 164: 3666-3674. (Pubitemid 30169821)
45. Choi, N. M., P. Majumder, and J. M. Boss. 2011. Regulation of major histocompatibility complex class II genes. Curr. Opin. Immunol. 23: 81-87.
46. Neerincx, A., G. M. Rodriguez, V. Steimle, and T. A. Kufer. 2012. NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner. J. Immunol. 188: 4940-4950.
47. Nekrep, N., M. Geyer, N. Jabrane-Ferrat, and B. M. Peterlin. 2001. Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome. Mol. Cell. Biol. 21: 5566-5576. (Pubitemid 32702460)
48. Scholl, T., S. K. Mahanta, and J. L. Strominger. 1997. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94: 6330-6334.
49. Zhu, X. S., M. W. Linhoff, G. Li, K. C. Chin, S. N. Maity, and J. P. Ting. 2000. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. Mol. Cell. Biol. 20: 6051-6061. (Pubitemid 30613053)
50. DeSandro, A. M., U. M. Nagarajan, and J. M. Boss. 2000. Associations and interactions between bare lymphocyte syndrome factors. Mol. Cell. Biol. 20: 6587-6599. (Pubitemid 30650243)
51. Garvie, C. W., J. R. Stagno, S. Reid, A. Singh, E. Harrington, and J. M. Boss. 2007. Characterization of the RFX complex and the RFX5(L66A) mutant: implications for the regulation of MHC class II gene expression. Biochemistry 46: 1597-1611.
52. Muhlethaler-Mottet, A., M. Krawczyk, K. Masternak, C. Spilianakis, A. Kretsovali, J. Papamatheakis, and W. Reith. 2004. The S box of major histocompatibility complex class II promoters is a key determinant for recruitment of the transcriptional co-activator CIITA. J. Biol. Chem. 279: 40529-40535. (Pubitemid 39287644)